focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTristel Regulatory News (TSTL)

Share Price Information for Tristel (TSTL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 440.00
Bid: 430.00
Ask: 450.00
Change: 0.00 (0.00%)
Spread: 20.00 (4.651%)
Open: 440.00
High: 440.00
Low: 440.00
Prev. Close: 440.00
TSTL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Dealing and Issue of Equity

2 May 2018 16:55

RNS Number : 9416M
Tristel PLC
02 May 2018
 

 

Tristel plc

("Tristel" or the "Company")

Director/PDMR Dealing and Issue of Equity

Tristel plc (AIM: TSTL), the manufacturer of infection prevention, contamination control and hygiene products, announces that on 2 May 2018 the Company has issued and allotted 140,000 new ordinary shares of 1 penny each in the Company ("Ordinary Shares"), following the exercise of 140,000 Ordinary Shares by Liz Dixon, Finance Director, at a weighted average exercise price of 56 pence per share. A number of the share options were due to expire in July 2018.

Liz Dixon subsequently sold 140,000 Ordinary Shares at a price of 300 pence per share. Liz Dixon's resultant holding is 45,000 Ordinary Shares representing 0.1% of the issued share capital of the Company and options over 709,888 Ordinary Shares.

Of the new Ordinary Shares sold, Francisco Soler acquired 60,000 Ordinary Shares at 300 pence per share. Francisco Soler's resultant holding is 8,473,834 Ordinary Shares (includes family and related corporate vehicles) representing 19.6% of the issued share capital of the Company.

Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 9 May 2018. The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 43,167,633 Ordinary Shares. Accordingly, the figure of 43,167,633 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information please contact:

 

Tristel plc

Tel: 01638 721 500

Paul Swinney, Chief Executive Officer

Liz Dixon, Finance Director

Walbrook PR Ltd

Tel: 020 7933 8780 or tristel@walbrookpr.com

Paul McManus

Mob: 07980 541 893

Lianne Cawthorne

Mob: 07854 391 303

finnCap

Tel: 020 7220 0500

Geoff Nash (Corporate Finance)

Giles Rolls (Corporate Finance)

Alice Lane (Corporate Broking)

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Liz Dixon

2.

Reason for the Notification

a)

Position/status

Director / PDMR

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 1p

Identification code

GB00B07RVT99

b)

Nature of the transaction

Exercise of options over Ordinary Shares and

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Exercise of Options

Exercise Price(s)

Volume(s)

£0.5375

£0.5375

£0.5375

£0.79

60,000

60,000

10,000

10,000

 

Sale of Ordinary Shares

 

Price(s)

Volume(s)

£3.00

140,000

d)

Aggregated information:

· Aggregated volume

· Price

See above

e)

Date of the transaction

2 May 2018

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Francisco Soler (through World Financial Trading Corporation and Atlas World Carriers S.A.)

2.

Reason for the Notification

a)

Position/status

Director / PDMR

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Tristel plc

b)

LEI

2138009DZ4LH9CZGF662

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

 

Ordinary shares of 1p

Identification code

GB00B07RVT99

b)

Nature of the transaction

 

Purchase of Ordinary Shares

c)

Price(s) and volume(s)

World Financial Trading Corporation

Price(s)

Volume(s)

£3.00

30,000

Atlas World Carriers S.A.

Price(s)

Volume(s)

£3.00

30,000

d)

Aggregated information:

· Aggregated volume

· Price

 

Purchase of 60,000 ordinary shares of 1p pence at 300 pence per Ordinary Share

e)

Date of the transaction

2 May 2018

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFKBDPPBKDNPK
Date   Source Headline
28th Apr 20147:00 amRNSTrading update
24th Apr 20147:00 amRNSSuccess in controlling Clostridium difficile rates
13th Mar 20147:00 amRNSPublic Health England tackle disease threats
3rd Mar 20147:01 amRNSGrant of Share Options
3rd Mar 20147:00 amRNSHalf Yearly Report
13th Feb 20147:00 amRNSInvestor Results Presentation
22nd Jan 20147:00 amRNSTrading Update and notice of results
10th Dec 20132:14 pmRNSResult of AGM
10th Dec 20137:00 amRNSAGM Statement
15th Nov 20137:00 amRNSPosting of Annual Report & Notice of AGM
18th Oct 20137:00 amRNSPeer-reviewed published article
14th Oct 20137:00 amRNSFinal Results
22nd Jul 20137:00 amRNSTrading Update & Notice of Results
28th May 20132:19 pmRNSDirector/PDMR Shareholding
29th Apr 20132:53 pmRNSHolding(s) in Company
15th Apr 20131:47 pmRNSHolding(s) in Company
10th Apr 201311:45 amRNSHolding(s) in Company
9th Apr 201311:18 amRNSDirectors' Shareholdings
21st Mar 20132:44 pmRNSHolding(s) in Company
4th Mar 20139:28 amRNSDirector Shareholding
4th Mar 20137:00 amRNSHalf Yearly Report
14th Feb 20137:00 amRNSTrading update and notice of results
18th Jan 20137:00 amRNSTristel Wipes System obtains approval in China
17th Jan 20137:00 amRNSPeer-reviewed published articles
11th Dec 201212:56 pmRNSResult of AGM
29th Oct 20127:00 amRNSFinal Results
29th Aug 20127:00 amRNSDirector/PDMR Shareholding
8th Aug 20127:00 amRNSDirectorate Change
2nd Aug 20127:00 amRNSNew website
23rd Jul 201210:29 amRNSDirector/PDMR Shareholding
23rd Jul 20127:00 amRNSTrading update
9th Jul 20127:00 amRNSSupply&distribution agreement - Basan Germany GmbH
25th Jun 20127:00 amRNSDirectorate Change
15th Jun 201211:40 amRNSDirectors' Shareholdings
15th Jun 20127:00 amRNSTrading Update
12th Jun 20127:00 amRNSResult of Clinical Study
30th Apr 20129:00 amRNSDirectors' Dealings
3rd Apr 20127:00 amRNSTermination of supply arrangement
30th Mar 20127:00 amRNSResults of Clinical Study
12th Mar 20127:00 amRNSHalf Yearly Report
8th Mar 20127:00 amRNSNotice of Results
11th Jan 20123:17 pmRNSDirector/PDMR Shareholding
4th Jan 20128:50 amRNSDirector/PDMR Shareholding
23rd Dec 201112:16 pmRNSDirector/PDMR Shareholding
21st Dec 20113:40 pmRNSGrant of Share Options
13th Dec 201111:52 amRNSResult of AGM
8th Dec 20114:24 pmRNSDirector/PDMR Shareholding
25th Nov 20111:22 pmRNSDirector/PDMR Shareholding
22nd Nov 20117:00 amRNSDirector's Dealing
11th Nov 201110:27 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.